Ropivacaine hydrochloride monohydrate (Standard)
Ropivacaine (hydrochloride monohydrate) (Standard) is the analytical standard of Ropivacaine (hydrochloride monohydrate). This product is intended for research and analytical applications. Ropivacaine hydrochloride monohydrate is a potent sodium channel blocker and blocks impulse conduction via reversible inhibition of sodium ion influx in nerve fibrese. Ropivacaine is also an inhibitor of K2P (two-pore domain potassium channel) TREK-1 with an IC50 of 402.7 μM in COS-7 cell's membrane. Ropivacaine is widely used for regional anesthesia and neuropathic pain management in vivo.
For research use only. We do not sell to patients.
- Purity : 98%
- CAS No.: 132112-35-7
- Formula: C17H29ClN2O2
- Molecular Weight:328.88
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Purity & Documentation
-
Help & FAQs
-
HY-B0563A
Ropivacaine hydrochloride monohydrate -
HY-B0285A
Amiloride hydrochloride -
HY-B0364A
Dyclonine hydrochloride -
HY-A0093
Mexiletine hydrochloride -
HY-B0285AR
Amiloride hydrochloride (Standard) -
HY-B0517A
Mepivacaine hydrochloride -
HY-B0364AR
Dyclonine hydrochloride (Standard) -
HY-B0517AR
Mepivacaine hydrochloride (Standard) -
HY-A0093R
Mexiletine hydrochloride (Standard)
Product Information
Information
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 132112-35-7
-
Molecular Weight 328.88
-
Formula C17H29ClN2O2
-
SMILES
O=C([C@H]1N(CCC)CCCC1)NC2=C(C)C=CC=C2C.O.Cl
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Dene Simpson, et al. Ropivacaine: a review of its use in regional anaesthesia and acute pain management. Drugs. 2005;65(18):2675-717. [Content Brief]
[2]. Li TF, et al. Epidural sustained release ropivacaine prolongs anti-allodynia and anti-hyperalgesia in developing and established neuropathic pain. PLoS One. 2015 Jan 24;10(1):e0117321. [Content Brief]
[3]. Hye Won Shin, et al. The inhibitory effects of bupivacaine, levobupivacaine, and ropivacaine on K2P (two-pore domain potassium) channel TREK-1. J Anesth. 2014 Feb;28(1):81-6. [Content Brief]
[4]. Milan Patel, et al. Ropivacaine Inhibits Pressure-Induced Lung Endothelial Hyperpermeability in Models of Acute Hypertension. Life Sci. 2019 Apr 1;222:22-28. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Ropivacaine hydrochloride monohydrate (Standard) Related Classifications
HY-B0563AR Related Classifications
Powered by Bioz